NEW YORK (GenomeWeb News) — The Immune Tolerance Network will use Sequenom’s MassArray technology and services for quantitative gene expression projects, the company said today.
 
The ITN, based out of the University of California, San Francisco, is a collaboration focused on developing, implementing, and soliciting assays and clinical strategies for tolerance studies of kidney, liver, and islet transplants, autoimmune diseases, allergy, and asthma.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.